1. Aghajanian, G. K., andR. S. Bunney: Central Dopaminergic Neurons: Neurophysiological Identification and Responses to Drugs. Frontiers in Catecholamines: III. Int. Catecholsymp. Straßburg, May 20?25, 1973.
2. Anton, A. H., andD. F. Sayre: The Distribution of Dopamine and Dopa in Various Animals and a Method for their Determination in Diverse Biological Material. J. Pharmacol. Exp. Ther.145, 326?336 (1964).
3. Ashcroft, G. W., andF. D. Sharman: Drug Induced Changes in the Concentration of 5-OR Indolyl Compunds in the Cerebrospinal Fluid and Caudate Nucleus. Brit. J. Pharmacol.19, 153?160 (1962).
4. Bartholini, G., M. Da Prada, andA. Pletscher: Decrease of Cerebral 5-Hydroxytryptamine by 3, 4-Dihydroxyphenylalanine after Inhibition of Extracerebral Decarboxylase. J. Pharm. Pharmac.20, 228?229 (1968).
5. Bernheimer, H., W. Birkmayer, andO. Hornykiewicz: Verteilung des 5-Hydroxytryptamins (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-Syndrom. Klin. Wschr.39, 1056 to 1059 (1961).